Login
E-mail
Password
Mostra password
Ricorda
Password dimenticata?
Iscriviti gratuitamente
Registrazione
Registrazione
Parametri
Parametri
Quotazioni dinamiche 
OFFON
  1. Home
  2. Azioni
  3. India
  4. Bombay Stock Exchange
  5. Aarti Drugs Limited
  6. Notizie
  7. Altre lingue
    524348   INE767A01016

AARTI DRUGS LIMITED

(524348)
RiassuntoGraficiNotizieRatingAgendaSocietąFinanzaConsensusRevisioni 
RiassuntoTutte le notizieAltre lingueComunicati stampaPubblicazioni ufficialiNotizie del settore
Notizie in altre lingue su AARTI DRUGS LIMITED
28/07AARTI DRUGS': Consolidated Profit Slumps Nearly 43% in Fiscal Q1
27/07Aarti Drugs Limited Reports Earnings Results for the First Quarter Ended June 30, 2021
17/07Aarti Drugs Limited Announces Demise of Ramdas Maneklal Gandhi, Independent Director
21/05Tranche Update on Aarti Drugs Limited's Equity Buyback Plan announced on March 19, 2021..
17/05AARTI DRUGS': Consolidated Profit Falls in Fiscal Q4
15/05Aarti Drugs Limited Reports Earnings Results for the Full Year Ended March 31, 2021
10/05Aarti Drugs Limited's Equity Buyback announced on March 19, 2021, has closed with 600,0..
04/05AARTI DRUGS: Crisil Affirms Ratings on Aarti Drug's Bank Loan; Outlook Stable
16/04AARTI DRUGS: ICRA Affirms Rating on Aarti Drugs' Term Loan; Outlook Stable
29/03AARTI DRUGS: ICRA Givers AA- Rating on Aarti Drugs' Term Loan; Outlook Stable
23/03AARTI DRUGS': Board Agrees to Buyback of Up to 600,000 Shares
22/03AARTI DRUGS: Board Approves Buyback of Shares Worth Over $8 Million
19/03Aarti Drugs Limited announces an Equity Buyback for 600,000 shares, representing 0.64% ..
19/03Aarti Drugs Limited authorizes a Buyback Plan.
16/03Aarti Drugs Limited's Board intends to launch an Equity Buyback on March 19, 2021.
08/03AARTI DRUGS: Drug Subsidiary Secures Indian Government Incentive for Pharmaceutical Secto..
22/02AARTI DRUGS: Closes Down UAE-Based Subsidiary
25/01Aarti Drugs Limited Reports Earnings Results for the Third Quarter Ended December 31, 2..
2020Aarti Drugs Limited Reports Earnings Results for the Second Quarter Ended September 30,..
2020Aarti Drugs Limited Declares the Interim Dividend INR 2.5 Per Equity Share for the Fina..
2020Aarti Drugs to Consider the Fund Raising
2020AARTI DRUGS LIMITED(BSE: 524348) added to S&P Global BMI Index
2020Aarti Drugs Limited Announces Board Changes
2020Nifty, Sensex end three days of gains on fears of prolonged slowdown
2020Aarti Drugs Limited Reports Earnings Results for the First Quarter Ended June 30, 2020
2020Aarti Drugs Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 202..
2020Aarti Drugs Limited Declares Interim Dividend for the Financial Year 2019-2020
2020Aarti Drugs Limited Reports Earnings Results for the Third Quarter Ended December 31, 2..
2019Aarti Drugs Limited Incorporates Marketing Subsidiary, Pinnacle Chile SpA in Chile
2019Aarti Drugs Limited Reports Earnings Results for the Second Quarter Ended September 30,..
2019Aarti Drugs Limited Reports Earnings Results for the First Quarter Ended June 30, 2019
2019Aarti Drugs Limited Recommends Dividend
2019Tranche Update on Aarti Drugs Limited's Equity Buyback Plan announced on March 15, 2019..
2019Aarti Drugs Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 201..
2019Aarti Drugs Limited's Equity Buyback announced on March 15, 2019, has closed with 282,1..
2019Aarti Drugs Limited Recommends Final Dividend the Financial Year 2018-19
2019Aarti Drugs Limited Appoints Rushikesh Deole as Company Secretary and Compliance Office..
2019Aarti Drugs Limited Announces Resignation of Vibhav S. Ranade as Company Secretary & Co..
2019Aarti Drugs Limited announces an Equity Buyback for 282,100 shares, representing 1.2% f..
2019Aarti Drugs Limited authorizes a Buyback Plan.
2019Aarti Drugs Limited's Board intends to launch an Equity Buyback.
2019Aarti Drugs Limited Reports Earnings Results for the Third Quarter Ended December 31, 2..
2018Aarti Drugs Limited Reports Earnings Results for the Second Quarter Ended September 30,..
2018Aarti Drugs Limited Reports Audited Standalone and Consolidated Earnings Results for th..
2018Aarti Drugs Limited Recommends Final Dividend
2018Aarti Drugs Limited Reports Audited Standalone and Consolidated Earnings Results for th..
2018Aarti Drugs Limited Recommends Final Dividend for the Financial Year Ended 2017-2018
2018Tranche Update on Aarti Drugs Limited's Equity Buyback Plan announced on January 8, 201..
2018Aarti Drugs Limited's Equity Buyback announced on January 8, 2018, has closed with 275,..
2018Aarti Drugs Limited Announces Unaudited Standalone and Consolidated Financial Results f..
2018Aarti Drugs Limited announces an Equity Buyback for 275,000 shares, representing 1.15% ..
2018Aarti Drugs Limited authorizes a Buyback Plan.
2018Aarti Drugs Limited's Board intends to launch an Equity Buyback on January 8, 2018.
2017Aarti Drugs Limited Announces Earnings Results for the Quarter Ended September 30, 2017
2017Aarti Drugs Limited Reports Audited Consolidated and Standalone Earnings Results for Fi..
2017Aarti Drugs Limited Recommends Final Dividend for the Financial Year Ended March 31, 20..
2017Aarti Drugs Limited Reports Audited Standalone and Consolidated Earnings Results for th..
2017Aarti Drugs Limited Reports Audited Standalone and Consolidated Earnings Results for th..
2016Tranche Update on Aarti Drugs Limited's Equity Buyback Plan announced on October 17, 20..
2016Aarti Drugs Limited's Equity Buyback announced on October 17, 2016 has closed with the ..
2016Aarti Drugs Ltd. Reports Audited Standalone and Consolidated Earnings Results for Secon..
2016Aarti Drugs Limited announces an Equity Buyback for 360,000 shares, representing 1.49% ..
2016Aarti Drugs Limited authorizes a Buyback Plan.
2016Aarti Drugs Limited's Board intends to launch an Equity Buyback on October 17, 2016.
2016Aarti Drugs Limited Reports Audited Consolidated and Standalone Earnings Results for Fi..
2016Aarti Drugs Limited Reports Audited Standalone and Consolidated Earnings Results for th..
Prossimo evento su AARTI DRUGS LIMITED
27/10/21